Large Independent Multi-Center Clinical Trial with Stratum Nutrition's NEM® Confirms Results in 7 Days

CARTHAGE, Mo. - Dec. 3, 2019 - PRLog -- Stratum Nutrition®, the Global Leader of eggshell and eggshell membrane wellness ingredients, and President, Micah Osborne, announce, "NEM® has become an internationally recognized joint health ingredient as supported in a large, double-blind, placebo-controlled Clinical Trial from Turkey."

The Journal of Arthritis (J Arthritis 8(4):285.) recently published a large independent multi-center, randomized double-blind, placebo-controlled trial evaluating the efficacy of Stratum's flagship ingredient, NEM® brand eggshell membrane, in 166 subjects diagnosed with Grade 2 or Grade 3 osteoarthritis of the knee.

This study was conducted at eight different university medical centers in Turkey and confirmed NEM®'s fast results in only 7 days. By Day 30, both knee pain and stiffness had improved by more than 30% in the NEM® -treated subjects. This study also employed a unique blinded, single-crossover design to compare subjects taking NEM® for 90 days versus subjects taking NEM® for 60 days (the former placebo subjects who began taking NEM® after Day 30). A responder analysis found a statistically significant difference between the number of patients having at least a 15% decrease in pain, which was greater in the 90-day NEM® group (71% of subjects) compared to the 60-day NEM® group (53% of subjects).

"This is the largest study conducted to date involving NEM® and we are pleased that it was supportive of its fast time to efficacy, even in subjects with moderate to severe arthritis. This, combined with its cartilage protecting effects recently demonstrated in healthy individuals, makes NEM® the perfect adjunctive therapy for those with joint issues," stated Kevin J. Ruff Ph.D., MBA – Sr. Director of Scientific & Regulatory Affairs for Stratum Nutrition.

For more information about Stratum Nutrition and its branded ingredients, please www.stratumnutrition.com.


About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, as well as oral-cavity probiotics, BLIS K12™ and BLIS M18™. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

NEM® & ESC® are trademarks of ESM Technologies, LLC, and are registered in the United States and other countries.

Ahiflower® is a registered trademark of Technology Crops International, LLC.

BLIS K12™ & BLIS M18™ are trademarks of Blis Technologies Limited and the subject of USA patent numbers 6773912 & 7226590.

Contact
Stratum Nutrition
***@stratumnutrition.com


Photos: (Click photo to enlarge)



Click to Contact
More Press Releases

Stocks rise as China confirms trade deal signing next week

Jul 9, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

China, Japan stocks lower on Christmas

Jul 9, 2020

Chinese and Japanese stocks declined Thursday while most other Asian markets were closed for Christmas Day. Tokyo's Nikkei 225 lost 0.1% to 23,806.72 while the Shanghai Composite Index was off 2 points at 2,982.80. Malaysia's benchmark was down 0.6% while Taiwan gained nine points. Wall Street ended nearly flat Tuesday in a shortened trading session before closing for Christmas Day. U.S. markets reopen Thursday. The benchmark S&P 500 index slipped less than 0.1% to 3,223.38. The Dow Jones Industrial Average dropped 0.1%, to 28,515.45. The Nasdaq composite gained 0.1% to 8,952.88. Investors have been encouraged by plans for an interim...

Stocks rise on Wall Street as rally stretches to fourth day

Jul 9, 2020

NEW YORK — U.S. stocks rallied Monday, rising with European and several Asian markets following surprisingly strong reports on China's economy. Growth in factory activity and retail sales in the world's second-largest economy both beat analysts’ expectations for last month. That layered on top of optimism from last week’s long-awaited “Phase 1” trade deal between China and the United States, which removed some of the uncertainty that’s hung over businesses and investors. The interim trade deal is one of a “trifecta of positive catalysts” that swept through the market last week and could help support it through the end of...

Cowboys render coin toss mix-up moot, throttle Rams 44-21

Jul 9, 2020

ARLINGTON, Texas — Dak Prescott and the Dallas Cowboys turned “much ado about nothing” over the coin toss into “win and they're in” next weekend. Prescott threw two touchdown passes after his confusing exchange with referee Walt Anderson made many think the Cowboys forced themselves to kick off to start both halves, and Ezekiel Elliott ran for two scores in a 44-21 victory over the Los Angeles Rams on Sunday. The Cowboys (7-7) ended their second three-game losing streak of the season, and the defending NFC East champions stayed even with Philadelphia atop the division with a showdown looming next...

Draghi stepped in during euro's darkest hour

Jul 9, 2020

FRANKFURT, Germany — Mario Draghi leaves as head of the European Central Bank credited with having rescued the eurozone from disaster with a well-timed phrase and bold action to back up his words. He expanded the bank's arsenal of crisis-fighting tools with new and unconventional policies, measures that he and others say helped end a financial crisis in 2010-2012 and create millions of jobs in the 19-country monetary union. Yet the closing days of his term have hardly been a victory lap. His departure is accompanied by an unusually public dispute among ECB board members over stimulus policies he pushed...

Subscribe to our newsletter!

Your Name

Your Email Address